Animal Health Market Report by Animal Type (Commercial, Companion), Product Type (Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics), and Region 2024-2032

Animal Health Market Report by Animal Type (Commercial, Companion), Product Type (Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A1156
Buy Now

Global Animal Health Market:

The global animal health market size reached US$ 37.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 49.5 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032. The market is driven by the growing number of pet owners and their desire for high-quality veterinary care, the rising awareness towards zoonotic diseases, and various technological advancements across the globe.

Report Attribute 
Key Statistics
Base Year
Forecast Years
Historical Years
Market Size in 2023
US$ 37.8 Billion
Market Forecast in 2032
US$ 49.5 Billion
Market Growth Rate 2024-2032 2.9%

Animal Health Market Analysis:

  • Major Market Drivers: Key drivers are the inflating pet ownership rates in developing countries and the elevating income levels of consumers, which are propelling the demand for advanced and specific veterinary products and services. Moreover, the expanding awareness towards the risks of zootonic diseases among farmers and pet owners is acting as another significant growth-inducing factor.
  • Key Market Trends: The increasing focus on preventive healthcare, escalating advancements in biotechnology and pharmaceuticals, and the emerging pet humanization and specialty pet care trends are among the key market trends.
  • Competitive Landscape: Some of the major market players in the animal health market include Bayer, Elanco, Merck, Merial, Zoetis Inc., Biogenesis Bago, Boehringer Ingelheim, Ceva Sante Animale, Heska, Neogen, Novartis, Thermo Fisher Scientific, Vetoquinol, and Virbac, among many others.
  • Geographical Trends: North America exhibits a clear dominance of the market, owing to its large population of pet owners and high levels of financial affluence, which encourages pet owners to prioritize the well-being and health of their pets.
  • Challenges and Opportunities: The major challenges affecting the animal health market are the escalating incidences of zootonic diseases, the rising resistance to antibiotics and related medications shown in certain species, and regulatory hurdles slowing the pace of research and development (R&D) activities. Key opportunities include the advent of digital health, advancements in biotechnology, and the elevating requirement for livestock products across the globe, which is driving the animal health market demand.

Global Animal Health Market Report

Animal Health Market Trends:

Increasing Focus On Preventive Healthcare

The animal health industry statistics suggest that it is experiencing a significant shift toward preventive healthcare practices for both companion animals and livestock. Pet owners and livestock producers recognize the importance of early detection and proactive management of health issues to improve overall animal well-being and reduce the risk of diseases. In May 2022, the Central Government of India implemented the Livestock Health and Disease Control Schemes with a budget of Rs 525 crores to control the economically essential livestock diseases and to undertake the necessary functions related to animal health in the country. Other than this, numerous factors are complemented by a desire to make animal husbandry more economical, as animal diseases account for 10-15% of production losses in livestock establishments. Preventive healthcare practices are also on the rise among Gen Z pet owners across countries. For example, in India, there has been a significant rise in pet owners’ visits to the veterinarian, regulation of timely vaccinations, and eagerness for feeding pets with balanced and nutritious diets. As per the data published by the Global Health Security Index, Mexico, the Ministry of Health published its National Health Promotion Days plan, which includes the Guidelines for Disease Prevention and Control Programs: Zoonosis. The recommendations reflect on the idea of One Health and notably address campaigns to stop and prevent the spread of brucellosis, rabies, and porcine tapeworm.

Advancements In Biotechnology and Pharmaceuticals

The animal health sector is witnessing rapid advancements in biotechnology and pharmaceuticals, which are transforming the way diseases are diagnosed and treated in animals. Cutting-edge research and innovative technologies have led to the development of specialized therapies, vaccines and precision medicines that are tailored to specific animal species and conditions. Biotechnological breakthroughs, such as gene editing, cell-based therapies, polymerase chain reaction (PCR), DNA sequencing, etc., offer promising solutions for challenging diseases. Additionally, pharmaceutical companies are investing in research and development (R&D) to create more effective and safer medications for animals. For instance, QBiotics Group Limited (QBiotics), an Australian life sciences company developing novel small molecule anticancer and wound healing pharmaceuticals, received approval from the Australian Pesticides and Veterinary Medicines Authority (APVMA) for the veterinary product STELFONTA (tigilanol tiglate). This approval represents Australia's first pharmaceutical treatment available for all grades of canine non-metastatic MCT. Biotechnology is facilitating the creation of advanced imaging technologies, including magnetic resonance imaging (MRI) and computed tomography (CT) scans, to provide detailed insights related to the internal structures and abnormalities in animals, including pets and livestock.

Growing Pet Humanization and Specialty Pet Care

The evolving relationship between humans and their pets has led to a phenomenon known as pet humanization. Pets are increasingly regarded as integral family members, resulting in a significant shift in consumer behavior in the pet care market. For example, in the US, 35% of young adults (aged 24 to 35) have either already become new pet owners or are planning to adopt a pet in their families soon and 19% of them brought home a new pet during the COVID-19 lockdown. Pet owners are willing to spend more on premium and specialized pet care products and services to ensure their beloved companions lead healthy and fulfilling lives. This trend has bolstered the demand for high-quality pet nutrition products, personalized treatments, advanced veterinary care, and a wide range of specialty items. For instance, the demand for pet care products, such as activity tracking collars, has risen recently, especially from the millennial or Gen Y generation, to measure their pet's agility and to play sports. For example, in the United Kingdom around 100,000 dogs have now been fitted with activity monitoring devices, according to PitPat, a leading manufacturer of dog activity monitors

Animal Health Market Segmentation

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on animal type and product type.

Breakup by Animal Type:

Animal Health Market

  • Commercial
  • Companion 

Commercial holds the largest animal health market share

A detailed breakup and analysis of the market based on the animal type has also been provided in the animal health industry overview and report. This includes commercial and companion. According to the report, commercial accounted for the largest market share.

The commercial segment typically includes animals, such as livestock and poultry, that are reared for commercial needs like milk and meat. Producers and farmers are increasingly focused on maintaining the health and productivity of their herds or flocks due to the rising demand for animal-derived products, including meat, dairy, and eggs. Healthy animals lead to higher yields and improved product quality, which directly impacts the profitability of commercial operations. To achieve optimal productivity, producers are investing in preventive healthcare measures, like vaccinations, parasite control, and disease management. This in turn, has augmented the demand for a wide range of animal health products, such as vaccines, pharmaceuticals, feed additives, and hygiene solutions. The rising collaboration between commercial animal producers and veterinary professionals ensures the implementation of best practices in animal health management, thus favoring the market growth. For instance, with an investment of up to US$ 10 Million the Asian Development Bank (ADB) signed an agreement to take a stake in Zenex Animal Health India Private Limited (Zenex) to increase Zenex's production and distribution of quality animal health care products and help boost farmer incomes by mitigating livestock disease risk.

Breakup by Product Type:

  • Pharmaceuticals 
  • Biologicals
  • Medicinal Feed Additives
  • Diagnostics 

Pharmaceuticals represent the most popular product type

The animal health industry report has provided a detailed breakup and analysis of the market based on the product type. This includes pharmaceuticals, biologicals, medicinal feed additives, and diagnostics. According to the report, pharmaceuticals represented the largest segment.

Pharmaceutical products cater to both companion animals and livestock, helping prevent and treat diseases, manage chronic conditions, and enhance overall animal well-being. Veterinary pharmaceutical companies are investing heavily in research and development (R&D) to create innovative and effective drugs tailored to specific animal species and health needs, thereby contributing to the segment growth. For instance, in March 2022, Hacarus Inc, launched its ECG platform, along with DS Pharma Animal Health. The device measures and analyzes the heart condition of dogs, to aid in the early detection of cardiac disease, the second leading cause of death for canines. Moreover, continuous advancements in pharmaceutical technologies, such as controlled-release formulations and personalized medicine, further optimize treatment outcomes. For instance, the Canadian Food Inspection Agency regulates veterinary biologics like vaccines to ensure that the products used on animals in the country are pure, potent, safe, and effective. The import of veterinary vaccines to the country needs a valid import permit issued by the CFIA-CCVB in Ottawa.

Breakup by Region:

Animal Health Market

To get more information on the regional analysis of this market, Request Sample

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America exhibits a clear dominance in the market 

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region has a large population of pet owners who prioritize the health and well-being of their companion animals, which has augmented demand for veterinary products and services. Moreover, the expanding livestock industry in North America fuels the need for animal health solutions to ensure the health and productivity of the commercial animal sector. Additionally, the presence of leading pharmaceutical companies and research institutions in the region that foster continuous innovation in animal health products, including vaccines, pharmaceuticals, and diagnostics has catalyzed the market growth. Another major contributing aspect is the introduction of supportive government regulations and initiatives promoting animal welfare and biosecurity, encouraging investments in the animal health industry, thereby propelling the market growth. In April 2022, Bovine somatotrophin, an animal growth hormone, was approved by the FDA to increase milk production in dairy cows. Government authorities are taking steps to encourage the participation of different players and various hormone therapies across the world to make the North American market a preferable choice.

Competitive Landscape:

  • The market is experiencing steady growth as key players are introducing several cutting-edge innovations to address evolving challenges and enhance animal care. They are developing advanced vaccines and therapeutics targeting specific diseases prevalent in both companion animals and livestock. Additionally, novel diagnostic tools employing advanced technologies, such as DNA testing and point-of-care devices, have been introduced by manufacturers to enable faster and more accurate disease detection.
  •  Key players are also investing in telemedicine and digital health solutions, facilitating remote consultations and personalized treatment plans for pet owners. Furthermore, the integration of data analytics and artificial intelligence (AI) technologies has improved decision-making in animal health management, optimizing treatment protocols and predictive modeling. These latest innovations by leading players in the market reflect their commitment to delivering state-of-the-art solutions and driving the animal health industry toward a more efficient and compassionate approach to animal care. We also expect the market to witness new entrants, consolidation of portfolios, and increased collaborations to drive healthy competition within the domain during the forecast period (2024-2032).

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the animal health industry top companies in the market include:

  • Bayer 
  • Elanco 
  • Merck
  • Merial 
  • Zoetis Inc.
  • Biogenesis Bago 
  • Boehringer Ingelheim
  • Ceva Sante Animale 
  • Heska 
  • Neogen 
  • Novartis 
  • Thermo Fisher Scientific 
  • Vetoquinol 
  • Virbac

Animal Health Market News:

  • February 2024: American animal health company Merck Animal Health, which focuses on developing veterinary pharmaceuticals, signed an agreement to acquire Indiana-based pharmaceutical manufacturing firm Elanco Animal Health’s aquatic-focused business for US$ 1.3 billion. The acquisition includes Elanco’s entire portfolio of medicines, vaccines, supplements, and nutritionals for aquatic species, two manufacturing facilities in Vietnam and Canada, as well as a research facility in Chile. The deal is expected to be finalised by mid-2024, subject to regulatory approvals.
  • December 2023: Canadian pharmaceutical manufacturing enterprise IntelGenx Corp. announced that it has entered into development and license agreements with a wholly owned subsidiary of US-based Covenant Animal Health Partners, LLC. Under the agreement terms, the latter will fund development and manufacturing of a drug for animal health based on IntelGenx’s VetaFilm drug delivery system. This marks IntelGenx’s third collaboration in three years as it expands its animal health business.
  • August 2023: Massachusetts-based Akston Biosciences announced that it would invent, develop and manufacture protein therapeutics for Delaware-based veterinary services firm Companion Animal Health. Akston Biosciences would be using its versatile Ambifect Fc-fusion platform along with its cGMP biologics manufacturing facility for the same. Akston is also spinning off its infectious disease vaccine business into a wholly-owned subsidiary named Vakston, Inc.

Animal Health Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Animal Type
  • Product Type
  • Region
Animal Types Covered Commercial, Companion
Product Types Covered Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Bayer, Elanco, Merck, Merial, Zoetis Inc., Biogenesis Bago, Boehringer Ingelheim, Ceva Sante Animale, Heska, Neogen, Novartis, Thermo Fisher Scientific, Vetoquinol, Virbac. etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the animal health market outlook from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global animal health market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the animal health industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.

Key Questions Answered in This Report

The global animal health market was valued at US$ 37.8 Billion in 2023.

We expect the global animal health market growth rate to exhibit a CAGR of 2.9% during 2024-2032.

The rising prevalence of numerous zoonotic diseases, along with the increasing R&D activities in the veterinary pharmaceutical industry, are currently driving the global animal health market.

The sudden outbreak of the COVID-19 pandemic has led to an increased attention towards the animal health to monitor the symptoms of coronavirus infection on animals and conduct necessary clinical research activities.

Based on the animal type, the global animal health market has been segmented into commercial and companion. Currently, commercial animals hold the majority of the total market share.

Based on the product type, the global animal health market can be divided into pharmaceuticals, biologicals, medicinal feed additives, and diagnostics. Among these, pharmaceuticals currently represent the largest market share.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global animal health market include Bayer, Elanco, Merck, Merial, Zoetis Inc., Biogenesis Bago, Boehringer Ingelheim, Ceva Sante Animale, Heska, Neogen, Novartis, Thermo Fisher Scientific, Vetoquinol, Virbac, etc.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Animal Health Market Report by Animal Type (Commercial, Companion), Product Type (Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics), and Region 2024-2032
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More